These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12653671)

  • 1. New paradigms in adjuvant systemic therapy of breast cancer.
    Thomas E; Hortobagyi GN
    Endocr Relat Cancer; 2003 Mar; 10(1):75-89. PubMed ID: 12653671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversies in breast cancer: adjuvant and neoadjuvant therapy.
    Montemurro F; Redana S; Valabrega G; Aglietta M
    Expert Opin Pharmacother; 2005 Jun; 6(7):1055-72. PubMed ID: 15957962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastatic breast cancer: what are the objectives?].
    Salvini P; Ripa C; Ginanni V
    Tumori; 2000; 86(5 Suppl 1):S22-8. PubMed ID: 11195289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors as adjuvant therapy in breast cancer.
    Visvanathan K; Davidson NE
    Oncology (Williston Park); 2003 Mar; 17(3):335-42, 347; discussion 347-50, 354. PubMed ID: 12661266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging role of aromatase inhibitors in the adjuvant setting.
    Goss PE
    Am J Clin Oncol; 2003 Aug; 26(4):S27-33. PubMed ID: 12902874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Breast International Group 1-98 trial: big results for women with hormone-sensitive early breast cancer.
    Monnier AM
    Expert Rev Anticancer Ther; 2007 May; 7(5):627-34. PubMed ID: 17492927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of early-stage breast cancer.
    Bookman MA; Goldstein LJ; Scher RM
    Curr Probl Cancer; 1991; 15(4):157-232. PubMed ID: 1874006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letrozole: a pharmacoeconomic review of its use in postmenopausal women with breast cancer.
    Dunn C; Keam SJ
    Pharmacoeconomics; 2006; 24(5):495-517. PubMed ID: 16706574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine therapy trials of aromatase inhibitors for breast cancer in the adjuvant and prevention settings.
    Ingle JN
    Clin Cancer Res; 2005 Jan; 11(2 Pt 2):900s-5s. PubMed ID: 15701884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
    Winer EP; Hudis C; Burstein HJ; Chlebowski RT; Ingle JN; Edge SB; Mamounas EP; Gralow J; Goldstein LJ; Pritchard KI; Braun S; Cobleigh MA; Langer AS; Perotti J; Powles TJ; Whelan TJ; Browman GP
    J Clin Oncol; 2002 Aug; 20(15):3317-27. PubMed ID: 12149306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors in breast cancer.
    Smith IE; Dowsett M
    N Engl J Med; 2003 Jun; 348(24):2431-42. PubMed ID: 12802030
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast cancer chemotherapy.
    McArthur HL; Hudis CA
    Cancer J; 2007; 13(3):141-7. PubMed ID: 17620762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
    Hamilton A; Volm M
    Oncology (Williston Park); 2001 Aug; 15(8):965-72; discussion 972, 977-9. PubMed ID: 11548977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors in postmenopausal breast cancer patients.
    Rieber AG; Theriault RL
    J Natl Compr Canc Netw; 2005 May; 3(3):309-14. PubMed ID: 16002003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatase inhibitors for breast cancer in postmenopausal women.
    Campos SM
    Oncologist; 2004; 9(2):126-36. PubMed ID: 15047917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Jahanzeb M
    Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity.
    Chlebowski RT; Haque R; Hedlin H; Col N; Paskett E; Manson JE; Kubo JT; Johnson KC; Wactawski-Wende J; Pan K; Anderson G
    Breast Cancer Res Treat; 2015 Dec; 154(3):609-16. PubMed ID: 26602222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.